Bone cells, sclerostin, and FGF23: What's bred in the bone will come out in the flesh

12Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bone metabolism is linked to systemic diseases, and new research shows that the bone cells have endocrine functions that affect multiple organs. They secrete sclerostin, FGF23, prostaglandins, and osteocalcin. Pereira et al. examined gene expression of cells grown from bone biopsies of adolescents with renal osteodystrophy, as a first step to understanding how the bone-cell abnormalities contribute to cardiovascular and metabolic problems in these patients.

Cite

CITATION STYLE

APA

Ott, S. M. (2015, March 1). Bone cells, sclerostin, and FGF23: What’s bred in the bone will come out in the flesh. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2014.360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free